Jefferies Starts Abivax (ABVX) at Buy

March 16, 2026 12:58 AM

Jefferies analyst Faisal Khurshid initiates coverage on Abivax (NASDAQ: ABVX) with a Buy rating and a price target of $160.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found